- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Astec LifeSciences Limited — Updates, 30-10-2025: Press Release
30-10-2025 | 12:39 pm
30-10-2025 | 12:39 pm
Astec LifeSciences announced Q2 & H1 FY26 results. Q2 EBITDA loss narrowed to ₹5.6 Cr (vs ₹17.7 Cr loss) driven by improved Enterprise business volumes and margins. Total income fell to ₹74.8 Cr, with contract manufacturing revenue declining significantly.
No comments yet. Be the first to comment!